Though there has been scrutiny of private equity acquisitions in healthcare, "the back end of corporate acquisitions -- the exit strategy -- has remained largely ignored, despite arguably being more important in the long run."
The cash component of the deal will be funded by FinTech IV’s $230 million in trust as well as a $125 million fully committed PIPE at $10 per share from institutional investors.
The SPAC intends to focus its search on targets bringing to market disruptive technologies in the blockchain/crypto and artificial intelligence technology sectors.